Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19 Read more
Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 Read more
Catalent Signs Agreement with J&J to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate Read more
Challenges in Supply and Partner-Sourcing for Stem-Gene – Clinical Trial Supply – A Virtual Experience Read more
Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm Read more
Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs License for Promising Drug to Treat Bone Cancer Read more